VILTOLARSEN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for viltolarsen and what is the scope of patent protection?

Viltolarsen is the generic ingredient in one branded drug marketed by Nippon Shinyaku and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Viltolarsen has forty-three patent family members in twenty countries.

Summary for VILTOLARSEN

International Patents:	43
US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Clinical Trials:	3
What excipients (inactive ingredients) are in VILTOLARSEN?	VILTOLARSEN excipients list
DailyMed Link:	VILTOLARSEN at DailyMed

Recent Clinical Trials for VILTOLARSEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NS Pharma, Inc.	Phase 4
Nippon Shinyaku Co., Ltd.	Phase 3
NS Pharma, Inc.	Phase 3

See all VILTOLARSEN clinical trials

US Patents and Regulatory Information for VILTOLARSEN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes	Start Trial	Start Trial	Y	Y		Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for VILTOLARSEN

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Hungary	E046364	Start Trial
European Patent Office	3581655	Start Trial
European Patent Office	3543341	Start Trial
Croatia	P20160336	Start Trial
Japan	2020072724	Start Trial
Serbia	59361	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.